Scinai Immunotherapeutics Ltd
NASDAQ:SCNI
Balance Sheet
Balance Sheet Decomposition
Scinai Immunotherapeutics Ltd
Scinai Immunotherapeutics Ltd
Balance Sheet
Scinai Immunotherapeutics Ltd
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
4
|
3
|
8
|
6
|
4
|
3
|
5
|
2
|
9
|
4
|
21
|
20
|
21
|
3
|
17
|
14
|
5
|
2
|
|
| Cash Equivalents |
4
|
3
|
8
|
6
|
4
|
3
|
5
|
2
|
9
|
4
|
21
|
20
|
21
|
3
|
17
|
14
|
5
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Assets |
4
|
3
|
8
|
7
|
5
|
5
|
6
|
3
|
9
|
7
|
22
|
21
|
21
|
3
|
18
|
14
|
5
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
2
|
8
|
12
|
14
|
14
|
13
|
12
|
11
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
12
|
11
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
4
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4
N/A
|
3
-24%
|
9
+180%
|
9
-3%
|
7
-18%
|
6
-13%
|
7
+20%
|
5
-36%
|
11
+124%
|
8
-26%
|
23
+200%
|
28
+21%
|
34
+18%
|
18
-47%
|
32
+81%
|
27
-16%
|
17
-35%
|
13
-23%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
6
|
5
|
1
|
2
|
1
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
6
|
5
|
20
|
2
|
2
|
2
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
38
|
2
|
22
|
20
|
19
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
5
|
6
|
9
|
0
|
0
|
6
|
1
|
1
|
|
| Total Liabilities |
0
N/A
|
0
-15%
|
1
+159%
|
1
+45%
|
0
-39%
|
0
-40%
|
1
+94%
|
0
-9%
|
2
+314%
|
1
-42%
|
7
+527%
|
37
+401%
|
52
+43%
|
22
-57%
|
25
+10%
|
29
+17%
|
22
-24%
|
3
-84%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
| Retained Earnings |
1
|
2
|
4
|
7
|
10
|
12
|
16
|
16
|
20
|
23
|
35
|
57
|
93
|
101
|
117
|
116
|
122
|
118
|
|
| Additional Paid In Capital |
5
|
5
|
12
|
15
|
17
|
18
|
23
|
20
|
28
|
29
|
52
|
48
|
74
|
97
|
125
|
116
|
120
|
124
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
| Total Equity |
4
N/A
|
3
-25%
|
8
+181%
|
8
-5%
|
7
-16%
|
6
-12%
|
7
+16%
|
4
-38%
|
9
+102%
|
7
-23%
|
16
+143%
|
8
N/A
|
19
-126%
|
5
+76%
|
8
N/A
|
2
N/A
|
5
-160%
|
10
N/A
|
|
| Total Liabilities & Equity |
4
N/A
|
3
-24%
|
9
+180%
|
9
-3%
|
7
-18%
|
6
-13%
|
7
+20%
|
5
-36%
|
11
+124%
|
8
-26%
|
23
+200%
|
28
+21%
|
34
+18%
|
18
-47%
|
32
+81%
|
27
-16%
|
17
-35%
|
13
-23%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
2
|
2
|
3
|
4
|
4
|
4
|
5
|
5
|
14
|
14
|
26
|
26
|
40
|
46
|
74
|
989
|
1 857
|
3 412
|
|